3rd COVAX/GAVI COVID 19 Vaccine Delivery to Chad
On December 3rd, the U.S. Embassy in Chad, in collaboration with the Ministry of Public Health and the World Health Organization, received a 3rd shipment of COVID-19 vaccine for Chad. This shipment of 170,300 Johnson & Johnson vaccines is part of a global U.S. effort to fight the COVID-19 pandemic and the U.S. commitment to deliver doses to Africa. That’s 250 million doses delivered worldwide – 50 million doses to 43 African countries – and more than 400,000 vaccines for Chadians.
The United States and international partners are working to distribute millions of doses of lifesaving COVID-19 vaccines to countries around the world. COVAX, an international partnership dedicated to equitable global access to vaccines, aims to distribute 2 billion doses of vaccine against COVID-19 by the end of 2021. COVAX is coordinated by Gavi, the Coalition for Epidemic Preparedness Innovations, UNICEF and the World Health Organization.
The United States contributed $2 billion to COVAX and has pledged an additional $2 billion through 2022. U.S. investments support the COVAX AMC to procure and deliver vaccines to low- and middle-income countries.
Our other bilateral donations via COVAX, to Chad as of January 2022 are:
- 117,000 Pfizer vaccine doses on October 2, 2021
- 115,830 Pfizer vaccine doses on October 30, 2021
- 170,000 Johnson & Johnson vaccine doses on November 27, 2021
- 149,760 Pfizer vaccine doses on January 7, 2022